LMNA and Hutchinson-Gilford progeria syndrome: In support of that view, a protein farnesyltransferase inhibitor (FTI) improves nuclear shape in progerin-expressing cells and ameliorates disease in knock-in and transgenic models of HGPS (11–13, 16, 26–28).